(PHAT) – Invest Chronicle

Home

Tag: (PHAT)

Right Now May Be the Best Buy-In Window for Phathom Pharmaceuticals Inc. (PHAT)

August 9, 2022 No Comments

For the readers interested in the stock health of Phathom Pharmaceuticals Inc. (PHAT). It is currently valued at $8.98. When the transactions were called off

Phathom Pharmaceuticals Inc. (PHAT): Get Prepared for Trading Lift Off

August 3, 2022 No Comments

At the end of the latest market close, Phathom Pharmaceuticals Inc. (PHAT) was valued at $9.07. In that particular session, Stock kicked-off at the price

Phathom Pharmaceuticals Inc. (PHAT): Are the Stars Lining Up for Investors?

June 22, 2022 No Comments

At the end of the latest market close, Phathom Pharmaceuticals Inc. (PHAT) was valued at $6.27. In that particular session, Stock kicked-off at the price

About Company

Investchronicle.com is an Economic news website, which offers broad information about the Stock markets and Equities. The major emphasis of this platform is to present, the most practical recommendation for public and private capital sharing, both in the form of updates and detailed analysis.

Quick Links

[class^="wpforms-"]